Stem definition | Drug id | CAS RN |
---|---|---|
anxiolytics, buspirone derivatives | 2112 | 150915-41-6 |
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
Dec. 22, 2000 | PMDA | Sumitomo Dainippon |
None
None
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Parkinsonism | 50.88 | 46.34 | 13 | 456 | 16571 | 79727348 |
Altered state of consciousness | 50.58 | 46.34 | 16 | 453 | 43806 | 79700113 |
None
Source | Code | Description |
---|---|---|
MeSH PA | D014150 | Antipsychotic Agents |
MeSH PA | D002491 | Central Nervous System Agents |
MeSH PA | D002492 | Central Nervous System Depressants |
MeSH PA | D011619 | Psychotropic Drugs |
MeSH PA | D014149 | Tranquilizing Agents |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Schizophrenia | indication | 58214004 | DOID:5419 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 8.29 | Basic |
pKa2 | 0.27 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
D(2) dopamine receptor | GPCR | ANTAGONIST | Ki | 9.22 | IUPHAR | IUPHAR | |||
D(3) dopamine receptor | GPCR | ANTAGONIST | Ki | 9.55 | IUPHAR | ||||
D(4) dopamine receptor | GPCR | ANTAGONIST | Ki | 10.05 | IUPHAR | ||||
5-hydroxytryptamine receptor 2A | GPCR | ANTAGONIST | Ki | 4.74 | IUPHAR |
ID | Source |
---|---|
D02372 | KEGG_DRUG |
C0084572 | UMLSCUI |
CHEBI:94777 | CHEBI |
CHEMBL1472975 | ChEMBL_ID |
DB08922 | DRUGBANK_ID |
C065533 | MESH_SUPPLEMENTAL_RECORD_UI |
115368 | PUBCHEM_CID |
7556 | IUPHAR_LIGAND_ID |
7237 | INN_ID |
129273-38-7 | SECONDARY_CAS_RN |
192052-81-6 | SECONDARY_CAS_RN |
N303OK87DT | UNII |
None